Tenet Healthcare Corp SEC filings THC

Tenet Healthcare Corp has 1,001 filings in SEC EDGAR's recent list, going back to Feb 13, 2015. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Tenet Healthcare Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
8-K Current report
Material agreement, New debt
Sep 22, 2026 Sep 22, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
144 Notice of proposed sale Sep 14, 2026 —
144 Notice of proposed sale Sep 10, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2026 Sep 8, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 4, 2026 —
4 Insider transaction Sep 3, 2026 Sep 2, 2026
144 Notice of proposed sale Sep 2, 2026 —
4 Insider transaction Sep 1, 2026 Aug 31, 2026
4 Insider transaction Aug 31, 2026 Aug 28, 2026
144 Notice of proposed sale Aug 31, 2026 —
4 Insider transaction Aug 26, 2026 Aug 24, 2026
4 Insider transaction Aug 26, 2026 Aug 24, 2026
144 Notice of proposed sale Aug 25, 2026 —
144 Notice of proposed sale Aug 24, 2026 —
144 Notice of proposed sale Aug 24, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
144 Notice of proposed sale Aug 7, 2026 —
144 Notice of proposed sale Aug 6, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
144 Notice of proposed sale Aug 5, 2026 —
4 Insider transaction Jul 31, 2026 Jul 29, 2026
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
144 Notice of proposed sale Jul 29, 2026 —
4 Insider transaction Jul 28, 2026 Jul 27, 2026
4 Insider transaction Jul 28, 2026 Jul 27, 2026
4 Insider transaction Jul 28, 2026 Jul 27, 2026
144 Notice of proposed sale Jul 27, 2026 —
144 Notice of proposed sale Jul 27, 2026 —
8-K Current report
Results of operations
Jul 23, 2026 Jul 23, 2026
4 Insider transaction May 29, 2026 May 28, 2026
8-K Current report
Shareholder vote results
May 29, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
144 Notice of proposed sale May 28, 2026 —
144 Notice of proposed sale May 27, 2026 —
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 22, 2026
3 Initial insider ownership May 8, 2026 May 1, 2026
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
ARS Annual report to shareholders Apr 16, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 16, 2026 —
DEF 14A Proxy statement Apr 16, 2026 May 27, 2026
8-K Current report
Officer or director change
Apr 10, 2026 Apr 9, 2026
8-K Current report
Officer or director change
Mar 30, 2026 Mar 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 13, 2026 Mar 11, 2026
144 Notice of proposed sale Mar 11, 2026 —
4 Insider transaction Mar 10, 2026 Mar 9, 2026
3 Initial insider ownership Mar 9, 2026 Feb 27, 2026
144 Notice of proposed sale Mar 9, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
4 Insider transaction Feb 17, 2026 Feb 13, 2026
4 Insider transaction Feb 17, 2026 Feb 13, 2026
4 Insider transaction Feb 17, 2026 Feb 13, 2026
4 Insider transaction Feb 17, 2026 Feb 13, 2026
4 Insider transaction Feb 17, 2026 Feb 13, 2026
10-K Annual report Feb 17, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 11, 2026 Feb 11, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Feb 2, 2026 Jan 27, 2026
4 Insider transaction Jan 2, 2026 Dec 31, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 15, 2025 —
8-K Current report
Officer or director change
Nov 24, 2025 Nov 21, 2025
8-K Current report
Material agreement, New debt
Nov 18, 2025 Nov 18, 2025
4 Insider transaction Nov 7, 2025 Nov 6, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
144 Notice of proposed sale Nov 6, 2025 —
4 Insider transaction Nov 5, 2025 Nov 3, 2025
8-K Current report
Material agreement, New debt
Nov 5, 2025 Nov 4, 2025
144 Notice of proposed sale Nov 5, 2025 —
144 Notice of proposed sale Nov 4, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Nov 3, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 3, 2025 —
4 Insider transaction Oct 31, 2025 Oct 29, 2025
4 Insider transaction Oct 31, 2025 Oct 29, 2025
144 Notice of proposed sale Oct 29, 2025 —
10-Q Quarterly report Oct 28, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
4 Insider transaction Sep 12, 2025 Sep 10, 2025
144 Notice of proposed sale Sep 10, 2025 —
4 Insider transaction Sep 2, 2025 Aug 29, 2025
4 Insider transaction Aug 29, 2025 Aug 28, 2025
4 Insider transaction Aug 22, 2025 Aug 20, 2025
4 Insider transaction Aug 21, 2025 Aug 19, 2025
144 Notice of proposed sale Aug 20, 2025 —
4 Insider transaction Aug 15, 2025 Aug 13, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
10-Q Quarterly report Jul 30, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 22, 2025 Jul 22, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
8-K Current report
Officer or director change
Jun 5, 2025 May 30, 2025
144 Notice of proposed sale Jun 5, 2025 —
144 Notice of proposed sale Jun 5, 2025 —
4 Insider transaction May 30, 2025 May 29, 2025
144 Notice of proposed sale May 29, 2025 —
4 Insider transaction May 28, 2025 May 27, 2025
4 Insider transaction May 28, 2025 May 27, 2025
4 Insider transaction May 28, 2025 May 27, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
4 Insider transaction May 27, 2025 May 22, 2025
144 Notice of proposed sale May 27, 2025 —
8-K Current report
Shareholder vote results
May 27, 2025 May 22, 2025
144 Notice of proposed sale May 27, 2025 —
144 Notice of proposed sale May 27, 2025 —
4 Insider transaction May 23, 2025 May 21, 2025
144 Notice of proposed sale May 23, 2025 —
144 Notice of proposed sale May 21, 2025 —
4 Insider transaction May 16, 2025 May 15, 2025
144 Notice of proposed sale May 15, 2025 —
4 Insider transaction May 12, 2025 May 9, 2025
144 Notice of proposed sale May 9, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 9, 2025 —
10-Q Quarterly report Apr 29, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 29, 2025 Apr 29, 2025
PX14A6G Filing Apr 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
ARS Annual report to shareholders Apr 11, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 11, 2025 —
DEF 14A Proxy statement Apr 11, 2025 May 22, 2025
4 Insider transaction Mar 12, 2025 Mar 11, 2025
4 Insider transaction Mar 12, 2025 Mar 11, 2025
144 Notice of proposed sale Mar 11, 2025 —
4 Insider transaction Mar 5, 2025 Mar 4, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
144 Notice of proposed sale Mar 4, 2025 —
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
10-K Annual report Feb 18, 2025 Dec 31, 2024
4 Insider transaction Feb 13, 2025 Feb 11, 2025
4 Insider transaction Feb 13, 2025 Feb 11, 2025
4 Insider transaction Feb 13, 2025 Feb 11, 2025
4 Insider transaction Feb 13, 2025 Feb 11, 2025
4 Insider transaction Feb 13, 2025 Feb 11, 2025
8-K Current report
Results of operations
Feb 12, 2025 Feb 12, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
8-K Current report
Officer or director change
Jan 24, 2025 Jan 23, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-General Medical & Surgical Hospitals, NEC (SIC 8062)
Listed as
THC (NYSE)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Dallas, TX
SEC filer status
Large accelerated filer
SEC CIK
70318
Former names
NATIONAL MEDICAL ENTERPRISES INC /NV/ (until Mar 27, 1995)

Other Services-General Medical & Surgical Hospitals, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.